KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Other Accumulated Expenses (2010 - 2021)

Resmed posted quarterly Other Accumulated Expenses of $12.3 million for Q2 2021, down 1.77% year-on-year from $12.5 million in Q2 2020, and down 1.77% on a QoQ basis from $12.5 million in Q2 2020.

Resmed (RMD) has 12 years of Other Accumulated Expenses data on file, last reported at $12.3 million in Q2 2021.

  • For the quarter ending Q2 2021, Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2021 stood at $12.3 million (down 1.77% YoY), and the FY2021 full-year result was $12.3 million, down 1.77% from the prior year.
  • Other Accumulated Expenses for Q2 2021 stood at $12.3 million, down from $12.5 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $41.2 million in Q2 2019 and bottomed at $10.9 million in Q2 2017.
  • The 5-year median for Other Accumulated Expenses is $12.3 million (2021), against an average of $17.6 million.
  • The widest annual swing landed in 2019, when Other Accumulated Expenses jumped 274.91%; it then tumbled 69.7% in 2020.
  • A 5-year view of Other Accumulated Expenses shows it stood at $10.9 million in 2017, then gained by 0.93% to $11.0 million in 2018, then surged by 274.91% to $41.2 million in 2019, then sank by 69.7% to $12.5 million in 2020, then dropped by 1.77% to $12.3 million in 2021.
  • The last three Other Accumulated Expenses figures came in at $12.3 million (Q2 2021), $12.5 million (Q2 2020), and $41.2 million (Q2 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 12.26 Mn
Jun 30, 2020 12.48 Mn
Jun 30, 2019 41.20 Mn
Jun 30, 2018 10.99 Mn
Jun 30, 2017 10.89 Mn
Jun 30, 2016 12.66 Mn
Jun 30, 2015 11.06 Mn
Jun 30, 2014 10.82 Mn
Jun 30, 2013 10.98 Mn
Jun 30, 2012 13.46 Mn
Jun 30, 2011 7.95 Mn
Jun 30, 2010 5.89 Mn